Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID.
Journal Information
Full Title: Respiration
Abbreviation: Respiration
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pulmonary Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of Interest Statement M.F.C. has received unrestricted grants and/or speaker fees from Boehringer Ingelheim, Roche and Novartis unrelated to this work. C.F.C. has received payments for lectures/speaking, development of educational materials, and travel/accommodation/meeting expenses/ advisory boards from Roche, Novartis, Boehringer, GSK, Astra Zeneca, Sanofi, Vifor, OM Pharma, and Mundipharma. C.v.G. has received honoraria for consulting, advisory role, or lectures from AstraZeneca, Boehringer Ingelheim, GSK, Mundipharma, Novartis, OM Pharma, Pfizer, PneumRx, and Pulmonx Sanofi. The other authors have no conflicts of interest to declare in relation to this work."
"Funding Sources No funding was received for this work."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025